Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Immunization in Lyme borreliosis--initial experience].

P Bartůnĕk1, V Mrázek

  • 1IV. interní klinika 1, LF UK a VFN, Praha.

Casopis Lekaru Ceskych
|July 28, 1999
PubMed
Summary

Lyme disease vaccination shows significant efficacy, preventing disease in vaccinated individuals. Studies confirm the vaccine is safe and effective, with mild side effects, offering a promising tool against Lyme disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nontoxic combretafuranone analogues with high in vitro antibacterial activity.

European journal of medicinal chemistry·2017
Same author

A review of a newly established ECMO program in a university affiliated cardiac center.

The Journal of cardiovascular surgery·2011
Same author

Significance of Borrelia infection in development of dilated cardiomypathy (a pilot study).

Prague medical report·2008
Same author

[The information value of detection of borrelia antibodies in the healthy blood donors and in the population at risk].

Casopis lekaru ceskych·2007
Same author

Lyme borreliosis infection as a cause of dilated cardiomyopathy.

Prague medical report·2006
Same author

[Endovascular treatment of acute vascular occlusions].

Casopis lekaru ceskych·2006

Area of Science:

  • Infectious Diseases
  • Vaccinology
  • Epidemiology

Context:

  • Rising Lyme disease incidence necessitates novel prevention strategies.
  • Current treatments for Lyme disease have limitations, driving vaccine development.
  • Previous vaccination efforts faced challenges, prompting research into improved vaccines.

Purpose:

  • To evaluate the efficacy and safety of a Lyme disease vaccine.
  • To summarize recent clinical trial data on Lyme disease vaccination in the U.S. and Europe.
  • To assess the vaccine's performance in preventing Borrelia burgdorferi infection.

Summary:

  • Two large U.S. studies (1994-1997) involving over 20,000 participants demonstrated vaccine efficacy ranging from 49% to 92% over two years.
  • The vaccine was found to be safe, with most adverse events being mild and transient local or systemic reactions.
  • European trials using a recombinant polyvalent vaccine showed promising results but involved a smaller cohort.

Impact:

  • The vaccine represents a significant advancement in Lyme disease prevention.
  • Successful vaccination could reduce the burden of Lyme disease, including chronic manifestations.
  • Further research and public health initiatives are needed to implement widespread Lyme disease vaccination.

Related Experiment Videos